$P102 Ultra hypofractionated radiotherapy after breast conservative surgery : analysis of acute skin toxicity$

P102 Ultra hypofractionated radiotherapy after breast conservative surgery : analysis of acute skin toxicity

Bibliographic Details
Main Authors:	M. Ben Rejeb, M. Mezghani, R. Moujahed, L. Ghorbel, A. Hamdoun, L. Kochbati
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	Breast
Online Access:	http://www.sciencedirect.com/science/article/pii/S0960977623002199

Similar Items

P100 Thyroid dose distribution during hypofractionated radiotherapy for breast cancer
by: M. Ben Rejeb, et al.
Published: (2023-03-01)

P097 Hypofractionated radiotherapy after neoadjuvant chemotherapy in Breast Cancer: Safety, feasibility, and early outcomes
by: G. Abdessatar, et al.
Published: (2023-03-01)

P108 Should we delineate brachial plexus in hypofractionated locoregional breast radiotherapy to reduce the risk of brachial plexopathy?
by: R. Moujahed, et al.
Published: (2023-03-01)

P290 Life without a breast : The underreported symptoms after radical mastectomy
by: M. Mezghani, et al.
Published: (2023-03-01)

P104 Hypofractionated radiotherapy in triple negative breast cancer: Does molecular subtype impact radiotherapy outcomes ?
by: M. Skouri, et al.
Published: (2023-03-01)

Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity
by: Tunesi Sara, et al.
Published: (2010-11-01)

Acute skin toxicity of ultra-hypofractionated whole breast radiotherapy with simultaneous integrated boost for early breast cancer
by: Angel Montero, et al.
Published: (2023-07-01)

Efficacy and Toxicity of Hypofractionated Palliative Radiotherapy for Breast Cancer Patients with Skin Invasion
by: Talha Maqsood, et al.
Published: (2023-08-01)

Ultra-Hypofractionated Whole Breast Radiotherapy with Automated Hybrid-VMAT Technique: A Pilot Study on Safety, Skin Toxicity and Aesthetic Outcomes
by: Boccardi M, et al.
Published: (2024-09-01)

Weekly ultra-hypofractionated radiotherapy in localised prostate cancer
by: Nora Sundahl, et al.
Published: (2024-07-01)

Robustness of hypofractionated breast radiotherapy after breast-conserving surgery with free breathing
by: Kunzhi Chen, et al.
Published: (2023-10-01)

Cardiopulmonary toxicities after hypofractionated radiotherapy in breast cancer
by: Budhi S Yadav
Published: (2022-01-01)

Concurrent Boost with Adjuvant Breast Hypofractionated Radiotherapy and Toxicity Assessment
by: Mona M. Sayed, et al.
Published: (2015-01-01)

Acute toxicity patterns and their management after moderate and ultra- hypofractionated radiotherapy for prostate cancer: A prospective cohort study
by: F. Sinzabakira, et al.
Published: (2024-09-01)

Ultra-hypofractionated one-week locoregional radiotherapy for patients with early breast cancer: Acute toxicity results
by: Ivica Ratosa, et al.
Published: (2024-05-01)

Intrafraction Prostate Motion Management for Ultra-Hypofractionated Radiotherapy of Prostate Cancer
by: Christoph Oehler, et al.
Published: (2022-08-01)

Successful Preoperative QUAD SHOT for Bulky Parotid Carcinoma: Potential Preoperative Ultra-Hypofractionated Radiotherapy for Conversion Surgery
by: Satoru Takahashi, et al.
Published: (2023-04-01)

Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: A systematic literature review
by: Martin Schmitt, et al.
Published: (2022-08-01)

Hypofractionated External-Beam Radiotherapy for Prostate Cancer
by: L. Chinsoo Cho, et al.
Published: (2013-01-01)

P095 Ultra-hypofractionated adjuvant radiotherapy in very elderly ratients with early breast cancer
by: P. Grigoropoulos, et al.
Published: (2023-03-01)

Influencing factors of radiation-induced skin injury induced by hypofractionated radiotherapy with simultaneous integrated boost for early breast cancer patients after breast-conserving surgery
by: SHAO Ruiyu, WANG Jianting, WANG Xiaohong
Published: (2025-01-01)

Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years
by: Marucci Laura, et al.
Published: (2010-01-01)

Cost-effectiveness analysis of ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy for intermediate- to high-risk localized prostate cancer
by: Jiaoxue He, et al.
Published: (2023-01-01)

Hypofractionated versus Conventional Postmastectomy Irradiation for Breast Cancer: Comparison of Acute Skin Toxicity
by: Wu Z, et al.
Published: (2024-07-01)

Implementation of ultra-hypofractionated radiotherapy schedules for breast cancer during the COVID-19 pandemic in the Netherlands
by: Anouk H. Eijkelboom, et al.
Published: (2024-07-01)

Effect of hypofractionated radiotherapy on lung functions in breast cancer patients
by: Enass A.A. Rezk, et al.
Published: (2023-01-01)

Hypofractionated stereotactic radiotherapy for brain metastases in lung cancer patients: dose‒response effect and toxicity
by: Kaicheng Pan, et al.
Published: (2024-07-01)

Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity
by: Imjai Chitapanarux, et al.
Published: (2019-10-01)

Hypofractionated radiotherapy regimens after organ-sparing surgery for stages I–IIa breast cancer
by: Yu. V. Efimkina, et al.
Published: (2014-08-01)

Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry
by: Andrew M. McDonald, et al.
Published: (2012-01-01)

Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost
by: Ioannis M. Koukourakis, et al.
Published: (2021-09-01)

Prospective Observational Study on Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer in Rwanda: Acute Toxicity in Patients
by: Felix Sinzabakira, et al.
Published: (2024-12-01)

Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity
by: David Thomson, et al.
Published: (2012-01-01)

A Study on Dosimetric Outcomes and Acute Toxicity of Post Mastectomy Adjuvant Hypofractionated Radiotherapy for Breast Cancer
by: Shivaprasad Deshmukh, et al.
Published: (2016-07-01)

Combinatorial hypofractionated radiotherapy and pembrolizumab in anaplastic thyroid cancer
by: Janice Ser Huey Tan, et al.
Published: (2024-02-01)

Efficiency of moderately hypofractionated radiotherapy in NSCLC cell model
by: Marcus Lüdeking, et al.
Published: (2024-04-01)

Extreme Hypofractionated Image-Guided Radiotherapy for Prostate Cancer
by: Carlo Greco
Published: (2013-09-01)

Cellular bases of hypofractionated radiotherapy protocols for lung cancer
by: ELIANA EVELINA OCOLOTOBICHE, et al.
Published: (2022-07-01)

Use of hypofractionated radiotherapy regimens after organ-sparing surgery for Stages I–IIA breast cancers
by: Yu. V. Efimkina, et al.
Published: (2014-08-01)

The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer
by: Lynsey Devlin, et al.
Published: (2022-09-01)